Patent · US Active

Therapy and kit for the prevention and treatment of cystic fibrosis

US9421239B2 · kind B2 · utility

1Cited by

3References

10Claims

0Family size

Assignee

TRUSTEES OF DARTMOUTH COLLEGE · US

Inventors

Dean R. Madden · Hanover, US
Patrick R. Cushing · Hanover, US
Prisca Boisguerin · St-Estève, FR
Rudolf Volkmer · Prenzlau, DE
Lars Vouilleme · Berlin, DE

Key dates

Filing date	May 22, 2015
Grant date	Aug 23, 2016
Priority date	—
Expiry date	May 22, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/4703
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination therapy and kit including an agent that inhibit the interaction between CAL and mutant CFTR proteins, in combination with a CFTR corrector, CFTR potentiator, mucolytic, anti-inflammatory agent or a combination thereof are provided as is a method for preventing or treating cystic fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.